Intellia Therapeutics (NTLA) Short Interest
Nasdaq • NTLA • US45826J1051
As of Oct 27, 2026, ORTEX estimated 32.6% of free float sold short, 7.7 days to cover, cost to borrow 0.44%. Sign up for live short interest data.
Nasdaq • NTLA • US45826J1051
As of Oct 27, 2026, ORTEX estimated 32.6% of free float sold short, 7.7 days to cover, cost to borrow 0.44%. Sign up for live short interest data.
This page tracks how heavily Intellia Therapeutics (Nasdaq:NTLA) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Intellia Therapeutics (Nasdaq: NTLA) has a market capitalization of $1.6B. Last close $11.41 (as of 2026-11-12); 52-week range $7.95 to $18.48. ORTEX data as of 2026-10-27: short interest was 32.62% of free float, 7.7 days to cover and the average cost to borrow was 0.44%. Sign up for live short interest data.